ALMKT:EPA
Mauna Kea Technologies SA
0,092 €
arrow_downward
−0,11%(−0,000100) 1 p
16. nov, 11:10:04 GMT +1 · EUR
search
Kõik sümbolid
| Sümbol | Hind | Muutus | % muutus |
|---|
insights_autoÜksuse ALMKT põhistatistika genereerimine…
Ava
0,09 €
Kõrge
0,09 €
Madal
0,09 €
Turu kapit.
18,46 mln
Keskm. maht
484,45 tuh
Maht
167,63 tuh
Hinna ja tulu suhe
0,79
52 näd kõrgeim
0,23 €
52 näd madalaim
0,07 €
Aktsiatulu
0,12 €
Käibivad aktsiad
195,26 mln
Töötajate arv
56
Ava
0,09 €
Kõrge
0,09 €
Madal
0,09 €
Turu kapit.
18,46 mln
Keskm. maht
484,45 tuh
Maht
167,63 tuh
Hinna ja tulu suhe
0,79
52 näd kõrgeim
0,23 €
52 näd madalaim
0,07 €
Aktsiatulu
0,12 €
Käibivad aktsiad
195,26 mln
Töötajate arv
56
Uudised
Veebiallikatest ja uudistepartneritelt
Business Insider
·
19 minuti eest
A veteran strategist sees a split in the stock market leading to a 15% drop in the S&P 500
Benzinga
·
36 minuti eest
Stock Market Today: Dow Jones, S&P 500 Futures Trade Mixed as Scott Bessent Presses Nvidia Over China Chi
Investing.com
·
1 tunni eest
Morgan Stanley raises S&P 500 target on earnings growth, lower oil and AI adoption
Billionaires.Africa
·
1 tunni eest
American billionaire Elon Musk's SpaceX eyes S&P 500 entry through Tesla merger
Profiil
Mauna Kea Technologies is a global medical device company focused on endomicroscopy, the field of microscopic imaging during endoscopy procedures. The company researches, develops and markets tools to visualize, detect, and rule out abnormalities including malignant and pre-malignant tumors or lesions in the gastrointestinal and pulmonary tracts.
The company makes Cellvizio, a probe-based Confocal Laser Endomicroscopy system, which provides physicians and researchers with real-time access to histological information during standard endoscopy procedures through high-resolution cellular imaging of internal tissues.
Cellvizio is used in medical applications such as gastrointestinal endoscopy, pulmonology and urology to help physicians diagnose lesions and make accurate treatment decisions in real-time.
Cellvizio went public in July 2011 and trades on the Euronext Paris exchange. Wikipedia
Teave üksuse Mauna Kea Technologies SA kohta
TegevjuhtSacha Loiseau
Töötajad56
Asutatud2000
Peakontorid-
SektorHealth Care
Valdkond-
Veebisaitmaunakeatech.com